
About Ubigene
Empowering Global Science Through Precision Gene Editing
Ubigene Biosciences is a global biotech innovator, co-founded by top-tier biological scientists from China, the United States, and France. Headquartered in a modern 3,000m² facility, we are dedicated to Gene Editing, Cell Biology Technologies, and Antibody Validation. With a presence in over 40+ countries, our expert teams have empowered thousands of scientists and institutions with customized gene-editing solutions.

What We Do

We offer end-to-end gene-editing solutions backed by proprietary technology platforms and scientific expertise. Our services and products include:
Our Core Services
Our Mission
Make genome editing easier
We are committed to advancing the future of biotechnology by simplifying complex workflows and accelerating scientific discovery through
innovation, integrity, and efficiency.
CRISPR-U™ Technology
CRISPR-U™ is the technique developed by Ubigene for gene editing in cell lines (based on CRISPR/Cas9). It includes a unique algorithm for designing gRNA based on cell genome characteristics, methods for exploring different gene-editing parameters for thousands of cell lines, precise detection of the editing efficiency of Cell Pool, methods for improving single-cell clone formation rates, and high-throughput identification of cellular genotypes.
Why Choose Ubigene?
Global Reach
40+ Countries Covered
Ubigene serves researchers across 40+ countries, empowering scientific progress globally.
10000+ Academic & Industry Partners
Ubigene is a trusted partner of over 10000 universities, biotech companies, and pharmaceutical enterprises worldwide.
Cell Line Bank & Resources
8000+ In-stock Cell Lines
Ubigene’s exclusive Red cotton OmniCell bank offers over 11000 cell lines for a wide range of research applications.
Expertise in Gene Editing
13000+ successful Edit
With over 15 years of exclusive experience and more than 13,000 successful gene edits, Ubigene ensures precision and excellence in every project.


